Khaskia Elias, Benhamou Raphael I
The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Heliyon. 2024 Dec 19;11(1):e41295. doi: 10.1016/j.heliyon.2024.e41295. eCollection 2025 Jan 15.
RNA-targeting small molecules, particularly RIBOnuclease TArgeting Chimeras (RIBOTACs), represent a powerful and promising therapeutic approach by selectively degrading RNAs through ribonuclease (RNase) recruitment. Despite their potential, the development of effective RNase recruitment tools is still in its early stages and remains a critical area of research. Ribonuclease L (RNase L) is a key ribonuclease targeted by RIBOTACs, yet the tools available for studying RNase L are limited. In this study, we introduce novel fluorescent ribonuclease binders that enhance the visualization and investigation of RNase L activity. Our findings provide new insights into RNase L dynamics and RNA degradation pathways, paving the way for more effective RNA-targeted degradation strategies. Furthermore, we explore the versatility of these conjugates for real-time tracking of RNase L localization, intracellular trafficking, and mechanistic studies. These fluorescent probes also enable high-throughput fluorescence-based assays to identify small molecules that bind and recruit RNase L, advancing RNA-targeted therapeutic approaches.
靶向RNA的小分子,特别是核糖核酸酶靶向嵌合体(RIBOTACs),通过招募核糖核酸酶(RNase)选择性降解RNA,代表了一种强大且有前景的治疗方法。尽管它们具有潜力,但有效的核糖核酸酶招募工具的开发仍处于早期阶段,仍然是一个关键的研究领域。核糖核酸酶L(RNase L)是RIBOTACs靶向的关键核糖核酸酶,但用于研究RNase L的工具有限。在本研究中,我们引入了新型荧光核糖核酸酶结合物,可增强对RNase L活性的可视化和研究。我们的研究结果为RNase L动力学和RNA降解途径提供了新的见解,为更有效的RNA靶向降解策略铺平了道路。此外,我们探索了这些结合物在实时跟踪RNase L定位、细胞内运输和机制研究方面的多功能性。这些荧光探针还能够进行基于高通量荧光的测定,以鉴定结合并招募RNase L的小分子,推动RNA靶向治疗方法的发展。